Video Experimental Relacionado

Updated: Jun 29, 2025

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

Biomarcadores del cáncer: tendencias emergentes e implicaciones clínicas para el tratamiento personalizado

Antonio Passaro¹, Maise Al Bakir², Emily G Hamilton³

¹Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy.

|March 29, 2024

Resumen

Los biomarcadores del cáncer están revolucionando la oncología y la medicina personalizada. Esta revisión cubre los hitos clave y las direcciones futuras para mejorar el manejo del tumor sólido y los resultados del paciente.

Área de la Ciencia:

En el campo de la oncología
Descubrimiento de biomarcadores
Medicina personalizada

Sus antecedentes:

Los biomarcadores del cáncer han transformado el tratamiento del cáncer y el pronóstico del paciente.
La medicina personalizada, guiada por perfiles moleculares de tumores, es un nuevo paradigma en el manejo del cáncer.

Objetivo del estudio:

Revisar los hitos científicos en el desarrollo de biomarcadores del cáncer.
Explorar las aplicaciones futuras de los biomarcadores en el tratamiento de tumores sólidos.

Principales métodos:

Revisión de la literatura científica sobre los biomarcadores del cáncer.
Análisis de los avances en biología del cáncer, metodologías de prueba y perfiles tumorales.

Principales resultados:

La integración de biomarcadores ha llevado a avances significativos en las terapias contra el cáncer.
El progreso es impulsado por la comprensión de la biología del cáncer, el microambiente inmune y el ADN circulante del tumor.

Conclusiones:

La integración continua de los conocimientos de los biomarcadores hará avanzar la oncología de precisión.
Las estrategias mejoradas de biomarcadores prometen mejores resultados en el tratamiento de tumores sólidos.

Más Videos Relacionados

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Videos de Conceptos Relacionados

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...